Skip to main content

Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022.

Publication ,  Journal Article
Miller, MJ; Cash-Goldwasser, S; Marx, GE; Schrodt, CA; Kimball, A; Padgett, K; Noe, RS; McCormick, DW; Wong, JM; Labuda, SM; Borah, BF; Yu, Y ...
Published in: MMWR Morb Mortal Wkly Rep
November 4, 2022

As of October 21, 2022, a total of 27,884 monkeypox cases (confirmed and probable) have been reported in the United States.§ Gay, bisexual, and other men who have sex with men have constituted a majority of cases, and persons with HIV infection and those from racial and ethnic minority groups have been disproportionately affected (1,2). During previous monkeypox outbreaks, severe manifestations of disease and poor outcomes have been reported among persons with HIV infection, particularly those with AIDS (3-5). This report summarizes findings from CDC clinical consultations provided for 57 patients aged ≥18 years who were hospitalized with severe manifestations of monkeypox¶ during August 10-October 10, 2022, and highlights three clinically representative cases. Overall, 47 (82%) patients had HIV infection, four (9%) of whom were receiving antiretroviral therapy (ART) before monkeypox diagnosis. Most patients were male (95%) and 68% were non-Hispanic Black (Black). Overall, 17 (30%) patients received intensive care unit (ICU)-level care, and 12 (21%) have died. As of this report, monkeypox was a cause of death or contributing factor in five of these deaths; six deaths remain under investigation to determine whether monkeypox was a causal or contributing factor; and in one death, monkeypox was not a cause or contributing factor.** Health care providers and public health professionals should be aware that severe morbidity and mortality associated with monkeypox have been observed during the current outbreak in the United States (6,7), particularly among highly immunocompromised persons. Providers should test all sexually active patients with suspected monkeypox for HIV at the time of monkeypox testing unless a patient is already known to have HIV infection. Providers should consider early commencement and extended duration of monkeypox-directed therapy†† in highly immunocompromised patients with suspected or laboratory-diagnosed monkeypox.§§ Engaging all persons with HIV in sustained care remains a critical public health priority.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

MMWR Morb Mortal Wkly Rep

DOI

EISSN

1545-861X

Publication Date

November 4, 2022

Volume

71

Issue

44

Start / End Page

1412 / 1417

Location

United States

Related Subject Headings

  • United States
  • Sexual and Gender Minorities
  • Population Surveillance
  • Mpox, Monkeypox
  • Mpox (monkeypox)
  • Minority Groups
  • Male
  • Humans
  • Homosexuality, Male
  • HIV Infections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Miller, M. J., Cash-Goldwasser, S., Marx, G. E., Schrodt, C. A., Kimball, A., Padgett, K., … CDC Severe Monkeypox Investigations Team. (2022). Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep, 71(44), 1412–1417. https://doi.org/10.15585/mmwr.mm7144e1
Miller, Maureen J., Shama Cash-Goldwasser, Grace E. Marx, Caroline A. Schrodt, Anne Kimball, Kia Padgett, Rebecca S. Noe, et al. “Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022.MMWR Morb Mortal Wkly Rep 71, no. 44 (November 4, 2022): 1412–17. https://doi.org/10.15585/mmwr.mm7144e1.
Miller MJ, Cash-Goldwasser S, Marx GE, Schrodt CA, Kimball A, Padgett K, et al. Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1412–7.
Miller, Maureen J., et al. “Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022.MMWR Morb Mortal Wkly Rep, vol. 71, no. 44, Nov. 2022, pp. 1412–17. Pubmed, doi:10.15585/mmwr.mm7144e1.
Miller MJ, Cash-Goldwasser S, Marx GE, Schrodt CA, Kimball A, Padgett K, Noe RS, McCormick DW, Wong JM, Labuda SM, Borah BF, Zulu I, Asif A, Kaur G, McNicholl JM, Kourtis A, Tadros A, Reagan-Steiner S, Ritter JM, Yu Y, Yu P, Clinton R, Parker C, Click ES, Salzer JS, McCollum AM, Petersen B, Minhaj FS, Brown E, Fischer MP, Atmar RL, DiNardo AR, Xu Y, Brown C, Goodman JC, Holloman A, Gallardo J, Siatecka H, Huffman G, Powell J, Alapat P, Sarkar P, Hanania NA, Bruck O, Brass SD, Mehta A, Dretler AW, Feldpausch A, Pavlick J, Spencer H, Ghinai I, Black SR, Hernandez-Guarin LN, Won SY, Shankaran S, Simms AT, Alarcón J, O’Shea JG, Brooks JT, McQuiston J, Honein MA, O’Connor SM, Chatham-Stephens K, O’Laughlin K, Rao AK, Raizes E, Gold JAW, Morris SB, CDC Severe Monkeypox Investigations Team. Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022 Nov 4;71(44):1412–1417.

Published In

MMWR Morb Mortal Wkly Rep

DOI

EISSN

1545-861X

Publication Date

November 4, 2022

Volume

71

Issue

44

Start / End Page

1412 / 1417

Location

United States

Related Subject Headings

  • United States
  • Sexual and Gender Minorities
  • Population Surveillance
  • Mpox, Monkeypox
  • Mpox (monkeypox)
  • Minority Groups
  • Male
  • Humans
  • Homosexuality, Male
  • HIV Infections